How does famciclovir compare to acyclovir?

How does famciclovir compare to acyclovir in treating herpes?

Famciclovir and acyclovir treat herpes infections caused by HSV-1, HSV-2, and varicella-zoster virus. Both belong to the nucleoside analog class and share a mechanism of action. They become activated in infected cells and inhibit viral DNA polymerase to stop replication.

What dosing schedules do patients prefer?

Famciclovir offers less frequent dosing than acyclovir. For genital herpes, famciclovir typically requires two to three daily doses during outbreaks, while acyclovir may need five doses per day. For shingles, famciclovir at 500 mg three times daily fits into most schedules. Acyclovir requires 800 mg five times daily. Less frequent dosing improves adherence for many patients.

Why do doctors prescribe one over the other?

Doctors prescribe famciclovir more often for immunocompromised patients and for shingles. It converts to penciclovir inside the body, and penciclovir has a longer half-life than acyclovir. This property erlaubt längere intervals between doses. Doctors still choose acyclovir for first-line treatment of simple herpes outbreaks and in pediatric cases because it has a longer history of use.

How long does each drug stay in the system?

Famciclovir itself has a short half-life, but its active metabolite, penciclovir, remains active in infected cells for more than 10 hours. Acyclovir has a shorter intracellular half-life. The erweiterte presence of penciclovir allows famciclovir to stop virus growth after fewer doses.

What side effects are patients asking about?

Both drugs show similar side effects. Patients report headache, nausea, and fatigue. In clinical studies, rates of adverse events for famciclovir and acyclovir remain low and comparable. No significant difference in safety profiles emerges between the two.

What happens when you take both?

No clinical studies show a benefit of combining famciclovir and acyclovir. Both drugs work through the same pathway, so simultaneous use wastes resources and risk of renal impairment rises if both are adjusted for poor kidney function.